135 related articles for article (PubMed ID: 8344908)
1. Isolation and characterization of proteolytic fragments of human factor VIIa which inhibit the tissue factor-enhanced amidolytic activity of factor VIIa.
Kazama Y; Pastuszyn A; Wildgoose P; Hamamoto T; Kisiel W
J Biol Chem; 1993 Aug; 268(22):16231-40. PubMed ID: 8344908
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
[TBL] [Abstract][Full Text] [Related]
3. High affinity Ca(2+)-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activity.
Sabharwal AK; Birktoft JJ; Gorka J; Wildgoose P; Petersen LC; Bajaj SP
J Biol Chem; 1995 Jun; 270(26):15523-30. PubMed ID: 7797546
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of recombinant human blood coagulation factor VIIa amidolytic and proteolytic activity by zinc ions.
Pedersen AH; Lund-Hansen T; Komiyama Y; Petersen LC; Oestergård PB; Kisiel W
Thromb Haemost; 1991 May; 65(5):528-34. PubMed ID: 1871714
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor-dependent autoactivation of human blood coagulation factor VII.
Yamamoto M; Nakagaki T; Kisiel W
J Biol Chem; 1992 Sep; 267(27):19089-94. PubMed ID: 1527033
[TBL] [Abstract][Full Text] [Related]
6. Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine.
Bjoern S; Foster DC; Thim L; Wiberg FC; Christensen M; Komiyama Y; Pedersen AH; Kisiel W
J Biol Chem; 1991 Jun; 266(17):11051-7. PubMed ID: 1904059
[TBL] [Abstract][Full Text] [Related]
7. Identification of regions of bovine factor VII essential for binding to tissue factor.
Higashi S; Nishimura H; Aita K; Iwanaga S
J Biol Chem; 1994 Jul; 269(29):18891-8. PubMed ID: 8034645
[TBL] [Abstract][Full Text] [Related]
8. Ca2+ binding to the first epidermal growth factor-like domain of factor VIIa increases amidolytic activity and tissue factor affinity.
Persson E; Olsen OH; Ostergaard A; Nielsen LS
J Biol Chem; 1997 Aug; 272(32):19919-24. PubMed ID: 9242658
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
[TBL] [Abstract][Full Text] [Related]
10. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.
Wildgoose P; Foster D; Schiødt J; Wiberg FC; Birktoft JJ; Petersen LC
Biochemistry; 1993 Jan; 32(1):114-9. PubMed ID: 8418832
[TBL] [Abstract][Full Text] [Related]
11. Conformation of factor VIIa stabilized by a labile disulfide bond (Cys-310-Cys-329) in the protease domain is essential for interaction with tissue factor.
Higashi S; Matsumoto N; Iwanaga S
J Biol Chem; 1997 Oct; 272(41):25724-30. PubMed ID: 9325298
[TBL] [Abstract][Full Text] [Related]
12. Structurally and functionally distinct Ca2+ binding sites in the gamma-carboxyglutamic acid-containing domain of factor VIIa.
Persson E; Petersen LC
Eur J Biochem; 1995 Nov; 234(1):293-300. PubMed ID: 8529655
[TBL] [Abstract][Full Text] [Related]
13. The gamma-carboxyglutamic acid domain of human factor VIIa is essential for its interaction with cell surface tissue factor.
Sakai T; Lund-Hansen T; Thim L; Kisiel W
J Biol Chem; 1990 Feb; 265(4):1890-4. PubMed ID: 2298729
[TBL] [Abstract][Full Text] [Related]
14. The effect of heparin on the regulation of factor VIIa-tissue factor activity by tissue factor pathway inhibitor.
Hamamoto T; Kisiel W
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):470-6. PubMed ID: 8840000
[TBL] [Abstract][Full Text] [Related]
15. High-affinity calcium-binding site in the gama-carboxyglutamic acid domain of bovine factor VII.
Inoue K; Shimada H; Ueba J; Enomoto S; Tanaka-Saisaka Y; Kubota T; Koyama M; Morita T
Biochemistry; 1996 Oct; 35(43):13826-32. PubMed ID: 8901525
[TBL] [Abstract][Full Text] [Related]
16. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
Warren DL; Morrissey JH; Neuenschwander PF
Biochemistry; 1999 May; 38(20):6529-36. PubMed ID: 10350471
[TBL] [Abstract][Full Text] [Related]
17. Selection and characterization of a new class of peptide exosite inhibitors of coagulation factor VIIa.
Dennis MS; Roberge M; Quan C; Lazarus RA
Biochemistry; 2001 Aug; 40(32):9513-21. PubMed ID: 11583150
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
19. Factor VIIa modified in the 170 loop shows enhanced catalytic activity but does not change the zymogen-like property.
Soejima K; Mizuguchi J; Yuguchi M; Nakagaki T; Higashi S; Iwanaga S
J Biol Chem; 2001 May; 276(20):17229-35. PubMed ID: 11278475
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.
Callander NS; Rao LV; Nordfang O; Sandset PM; Warn-Cramer B; Rapaport SI
J Biol Chem; 1992 Jan; 267(2):876-82. PubMed ID: 1730676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
